Dehydroepiandrosterone's antiepileptic action in FeCl3-induced epileptogenesis involves upregulation of glutamate transporters

Epilepsy Research

Volumn 106, Issue 1-2, 2013, Pages 83-91

  Mishra, Monika ^a   Singh, Rameshwar ^a   Mukherjee, Somnath ^a   Sharma, Deepak ^a  

^a JAWAHARLAL NEHRU UNIVERSITY   (India)

Author keywords

Antiepileptic action; Dehydroepiandrosterone; Glutamate transporters; Iron induced epilepsy; MRNA expression; Post traumatic epilepsy

Indexed keywords

EXCITATORY AMINO ACID TRANSPORTER 1; FERRIC CHLORIDE; GLUTAMATE TRANSPORTER; GLUTAMIC ACID; MESSENGER RNA; PRASTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; DRUG TARGETING; EPILEPSY; HIPPOCAMPUS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UPREGULATION;

ANTIEPILEPTIC ACTION; DEHYDROEPIANDROSTERONE; GLUTAMATE TRANSPORTERS; IRON-INDUCED EPILEPSY; MRNA EXPRESSION; POST-TRAUMATIC EPILEPSY;

AMINO ACID TRANSPORT SYSTEM X-AG; ANIMALS; ANTICONVULSANTS; CHLORIDES; DEHYDROEPIANDROSTERONE; ELECTROENCEPHALOGRAPHY; ELECTROPHYSIOLOGICAL PROCESSES; EPILEPSY; EXCITATORY AMINO ACID TRANSPORTER 1; EXCITATORY AMINO ACID TRANSPORTER 2; EXCITATORY AMINO ACID TRANSPORTER 3; FERRIC COMPOUNDS; GLUTAMIC ACID; MALE; POLYMERASE CHAIN REACTION; RATS; RATS, WISTAR; RNA; SEIZURES;

EID: 84883288907     PISSN: 09201211     EISSN: 18726844     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2013.06.008     Document Type: Article

References (55)

1. Akbar M.T., Torp R., Danbolt N.C., Levy L.M., Meldrum B.S., Ottersen O.P. Expression of glial glutamate transporters GLT-1 and GLAST is unchanged in the hippocampus in fully kindled rats. Neuroscience 1997, 78:351-359.
2. Aragno M., Parole S., Brignardello E., Mauro M., Tamagno E., Manti R., Danni O., Boccuzzi G. Dehydroepiandrosterone prevents oxidation injury induced by transient ischemia/reperfusion in the brain of diabetic rats. Diabetes 2000, 49:1924-1931.
3. Backstrom T., Landgren A., Zetterlund, Blom S., Dubrovsky B., Bixo M., Sodergard H. Effects of ovarian steroid hormones on brain excitability and their relation to epilepsy seizure variation during the menstrual cycle. Adv. Epileptol. 1984, 15:269-277.
4. Bastianetto S., Ramassamy C., Poirier J., Quirion R. Dehydroepiandrosterone (DHEA) protects hippocampal cells from oxidative stress-induced damage. Mol. Brain Res. 1999, 66:35-41.
5. Baulieu E., Robel E.P. Dehydroepiandrosterone and dehydroepiandrosterone sulphate as neuroactive neurosteroids. J. Endocrinol. 1996, 150:221-239.
6. Baulieu E.E., Robel P., Schumacher M. Neurosteroids beginning of the story. Int. Rev. Neurobiol. 2001, 46:1-32.
7. Bergeron R., Montigny C., Debonnel G. Potentiation of neuronal NMDA response induced by dehydroepiandrosterone and its suppression by progesterone: effects mediated via sigma receptors. J. Neurosci. 1996, 16:1193-1202.
8. Beyenburg S., Stoffel-Wagner B., Bauer J., Watzkaa M., Blümckec I., Bidlingmaierb F., Elgera C.E. Neuroactive steroids and seizure susceptibility. Epilepsy Res. 2001, 44:141-153.
9. Bouilleret V., Boyet S., Marescaux C., Nehlig A. Mapping of progressive metabolic changes occurring during the development of hippocampal sclerosis in a model of mesial temporal lobe epilepsy. Brain Res. 2000, 852:255-262.
10. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of dye binding. Anal. Biochem. 1976, 72:248-254.
11. Budziszewska B., Siwanowicz J., Leokiewicz M., Jaworka-Feil L., Lason W. Protective effect of neurosteroids against NMDA-induced seizures and lethality in mice. Eur. Neuropsychopharmacol. 1998, 8:7-12.
12. Charalampopoulos I., Lazaridis I., Gravanis A. Neuroprotective and neurogenic properties of dehydroepiandrosterone and its synthetic analogs. Hormone in Neurodegeneration, Neuroprotection, and Neurogenesis 2011, 137-154. Wiley-VCH Verlag Gmbh Co K GaA, Weinheim. A.G. Gravanis, S.H. Mellon (Eds.).
13. D'Ambrosio R., Fairbanks J.P., Fender J.S., Born D.E., Doyle D.L., Miller J.W. Post-traumatic epilepsy following fluid percussion injury in the rat. Brain 2004, 127:304-314.
14. D'Ambrosio R., Fender J.S., Fairbanks J.P., Simon E.A., Born D.E., Doyle D.L., Miller J.W. Progression from frontal-parietal to mesial temporal lobe epilepsy after fluid percussion injury in the rat. Brain 2005, 128:174-188.
15. 3+-induced epileptogenesis. Mol. Brain Res. 2000, 75:105-112.
16. 3+-induced epileptogenesis. Mol. Brain Res. 2001, 92:107-114.
17. 2+ channel current in freshly isolated hippocampal CA1 neurons. Eur. J. Pharmacol. 1991, 202:269-272.
18. Frye C.A. Hormonal influence on seizures: basic neurobiology. Int. Rev. Neurobiol. 2008, 83:27-77.
19. Frye C.A., Reed T.A.W. Androgenic neurosteroids: anti-seizure effects in animal model of epilepsy. Psychoneuroendocrinology 1998, 23:385-399.
20. Geddes J.W., Wood J.D. Changes in the amino acid content of nerve endings (synaptosomes) induced by drugs that alter the metabolism of glutamate and γ-aminobutyric acid. J. Neurochem. 1984, 42:16-24.
21. Handforth A., Ackermann R.F. Mapping of limbic seizure progressions utilizing the electrogenic status epilepticus model and the 14 C-2-deoxyglucose method. Brain Res. Rev. 1995, 20:1-23.
22. Herzog A.G., Klein P., Jacobs A.R. Testosterone versus testosterone and testolactone in treating reproductive and sexual dysfunction in men with epilepsy and hypogonadism. Neurology 1998, 50:782-784.
23. Johansson T., Le Greve's P. The effect of dehydroepiandrosterone sulphate and allopregnanolone sulfate on the binding of [(3)H] ifenprodil to N-methyl-d-aspartate receptor in rat frontal cortex membrane. J. Steroid Biochem. Mol. Biol. 2005, 94:263-266.
24. Leppik I.E. Epilepsy in the elderly: scope of the life problem. Int. Rev. Neurobiol. 2007, 81:1-14.
25. Lund P. l-Glutamine and l-glutamate: UV method with glutaminase and glutamate dehydrogenase. Methods in Enzymatic Analysis 1986, Vol. 8:357-363. VCH, Verlagsgesellschaft, Weinhein.
26. Mattson M.P. Modification of ion homeostasis by lipid peroxidation: role in neuronal degeneration and adaptive plasticity. Trends Neurosci. 1998, 21:53-57.
27. Maurice T., Lockhart B.P. Neuroprotective and anti-amnesic potentials of sigma receptor ligands. Prog. Neurol. Psychopharmacol. Biol. Psychiatry 1997, 21:69-102.
28. Maurice T., Phan V.L., Urani A., Kamei H., Noda Y., Nabeshima T. Neuroactive neurosteroids as endogenous effectors for sigma1 receptor: pharamocological evidence and therapeutic opportunities. Jpn. J. Pharmacol 1999, 81:125-155.
29. Mishra M., Singh R., Sharma D. Antiepileptic action of exogenous dehydroepiandrosterone in iron-induced epilepsy in rat brain. Epilepsy Behav. 2010, 19:264-271.
30. Moriwaki A., Hattori Y., Hayashi Y., Hori Y. Development of epileptic activity induced by iron injection into rat cerebral cortex: electrographic and behavioral characteristics. Electroencephalogr. Clin. Neurophysiol. 1992, 83:281-288.
31. Nonaka M., Kohmura E., Yamashita T., Shimada S., Tanaka K., Yoshimine T., Tohyama M., Udea T.H. Increased transcription of glutamate-aspartate transporter (GLAST/GluT-1) mRNA following kainic acid-induced limbic seizure. Mol. Brain Res. 1998, 55:54-60.
32. Paxinos G., Watson C. The Rat Brain In Stereotaxic Coordinates 2010, Academic Press, New York.
33. Persad V., Guin, Ting, Wong C., Cortez M.A., Wang Y.T., Snead O. Hormonal regulation of atypical absence seizures. Ann. Neurol. 2004, 55:353-361.
34. Racchi M., Govoni S., Solerte S.B., Galli C.L., Corsini E. Dehydroepiandrosterone and the relationship with aging and memory: a possible link with protein kinase C functional machinery. Brain Res. Rev. 2001, 37:287-293.
35. Rakhade S.N., Loeb J.A. Focal reduction of neuronal glutamate transporters in human neocortical epilepsy. Epilepsia 2008, 49:226-236.
36. Ronne-Engström E., Hillered L., Flink R., Kihlström L., Lindquist C., Nie J.X., Olsson Y., Silander H.C. Extracellular amino acid levels measured with intracerebral microdialysis in the model of posttraumatic epilepsy induced by intracortical iron injection. Epilepsy Res. 2001, 43:135-144.
37. Rupprecht R., Holsboer F. Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives. Trends Neurosci. 1999, 22:410-416.
38. Samuelsson C., Kumlien E., Elfving A., Lindholm D., Ronne-Engström E. The effects of PBN (phenyl-butyl-nitrone) on GLT-1 levels and on the extracellular levels of amino acids and energy metabolites in a model of iron-induced post-traumatic epilepsy. Epilepsy Res. 2003, 56:165-173.
39. Samuelsson C., Kumlien E., Flink R., Lindholm D., Ronne-Engström E. Decreased cortical levels of astrocytic glutamate transport protein GLT-1 in a rat model of post-traumatic epilepsy. Neurosci. Lett. 2000, 289:185-188.
40. Sandhir R., Julka D., Gill K.D. Exacerbated glial response in the aged mouse hippocampus following controlled cortical impact injury. Exp. Neurol. 2008, 213:372-380.
41. Sharma D., Maurya A.K., Singh R. Age-related decline in multiple unit action potentials of CA3 region of rat hippocampus: correlation with lipid peroxidation and lipofuscin concentration and the effect of centrophenoxine. Neurobiol. Aging 1993, 14:319-330.
42. Sharma V., Singh R. Electroencephalographic study of iron-induced chronic focal cortical epilepsy in rat: propagation of cortical epileptic activity to substantia nigra and thalamus. Indian J. Exp. Biol. 1999, 37:461-467.
43. Sharma V., Prakash-Babu P., Singh A., Singh S., Singh R. Iron-induced experimental cortical seizures: electroencephalographic mapping of seizure spread in the subcortical brain areas. Seizure 2007, 16:680-690.
44. Sheldon A.L., Robinson M.B. The role of glutamate transporters in neurodegenerative disease and potential opportunities for intervention. Neurochem. Int. 2007, 51:333-355.
45. Silva-Barrat C., Menini C., Bryere P., Naquet R. Multiunitary activity analysis of cortical and subcorticle structures in paroxysmal discharges and grand mal seizure in photosensitive baboons. Electroencephalogr. Clin. Neurophysiol. 1987, 64:455-468.
46. 3 induced epileptogenic foci in the rat brain. Epilepsia 1990, 31:15-26.
47. Sinha N., Baquer N.Z., Sharma D. Anti-lipidperoxidative role of exogenous dehydroepiandrosterone (DHEA) administration in normal ageing rat brain. Indian J. Exp. Biol. 2005, 43:420-424.
48. Taha A., Mishra M., Baquer N., Sharma Z.D. Na+, K+-ATPase activity in response to exogenous dehydroepiandrosterone administration in ageing rat brain. Indian J. Exp. Biol. 2008, 46:852-854.
49. Tan M., Tan U. Effect of testosterone and clomiphene on spectral EEG and visual evoked response in a young man with post-traumatic epilepsy. Int. J. Neurosci. 2001, 106:87-94.
50. Trotti D., Danbolt N.C., Volterra A. Glutamate transporters are oxidant-vulnerable: a molecular link between oxidative and excitotoxic neurodegeneration?. Trends Pharmacol. Sci. 1998, 19:328-334.
51. 3+-induced epileptogenesis. Epilepsy Res. 2000, 39:201-209.
52. Van Gelder N.M., Sherwin A.L., Rasmussen T. Amino acid content of epileptogenic human brain: focal versus surrounding regions. Brain Res. 1972, 40:385-393.
53. Wen S., Dong K., Onolfo J.P., Vincens M. Treatment with dehydroepiandrosterone sulfate increases NMDA receptors in hippocampus and cortex. Eur. J. Pharmacol. 2001, 430:373-374.
54. Willmore L.J., Sypert G.W., Munson J.B. Recurrent seizures induced by cortical iron injection: a model of post traumatic epilepsy. Ann. Neurol. 1978, 4:329-336.
55. Zhang W.Q., Mundy R.W., Thai L., Hudson P.M., Gallagher M., Tilson H.A., Hong J.S. Decreased glutamate release correlates with elevated dynorphin content in the hippocampus of aged rats with spatial learning deficits. Hippocampus 1991, 1:391-397.